Parkinson's Disease Neuroprotection Clinical Trial
Scott, Burton L.
Duke University, Durham, NC, United States
See 16 grants from Burton Scott
See 30818 grants from Duke University
Recent in Grantomics:
University of Virginia
vs. funders. Who wins?
How should you pick the next fundable research topic?
Recently viewed grants:
White Adipose Tissue Physiology, Mitochondrial Function and Adiponectin
Impact of the FGF21-Adiponectin-Ceramide Axis on Healthspan
Therapeutic targeting of aberrant glial function during Juvenile Batten Disease
Cell cycle regulators control adiposity and metabolism
Prices in Space and Time
Recently added grants:
Galectin-3: A mediator of vascular remodeling in pulmonary arterial hypertension
T-Cells and P. Carinii Pneumonia
Determinants and Prognostic Significance of Proximal Aortic Stiffness
Fibrinogen and Factor XIII in Venous Thrombosis
Racial and Ethnic Health Disparities Due to Ambulance Diversion
National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Cooperative Clinical Research--Cooperative Agreements (U10)
Special Emphasis Panel (ZNS1-SRB-B (34))
Moy, Claudia S
Schools of Medicine
Mauldin, Patrick D; Guimaraes, Paulo; Albin, Roger L et al.
Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudy.
Clin Ther 30:1553-7
Be the first to comment on Burton Scott's grant
Share this grant: